Sign in

CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company

Compass Therapeutics, Inc.

Sign in to watch
Ticker
CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8099
Business address
80 GUEST STREET, BOSTON, MA, 02135
Former names
Olivia Ventures, Inc.
  1. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.98 ($79,600)
  2. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.86 ($77,200)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 500,000 shares (grant or award)
  10. 4 Grant or award Chief Operating Officer acquired 400,000 shares (grant or award)
  11. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $4.05 ($81,000)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $4.19 ($83,800)
  13. 4 Open-market sale Chief Operating Officer sold 24,500 shares at an average $4.23 ($103,708)
  14. 4 Open-market sale Chief Operating Officer sold 22,261 shares at an average $4.36 ($96,986)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 402,000 shares at $3.21 ($1,290,420)
  17. 4 Open-market buy Director bought 402,000 shares at $3.21 ($1,290,420)
  18. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.32 ($23,200)
  19. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.27 ($34,050)
  20. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $3.03 ($45,450)

Page 4 of 8 · 142 filings